MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ
5.43
+0.02
+0.37%
Pre Market: 5.74 +0.31 +5.77% 09:16 04/15 EDT
OPEN
6.02
PREV CLOSE
5.41
HIGH
6.03
LOW
5.20
VOLUME
8.37K
TURNOVER
10.90K
52 WEEK HIGH
30.50
52 WEEK LOW
2.900
MARKET CAP
37.26M
P/E (TTM)
-0.7549
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PSTV last week (0406-0410)?
Weekly Report · 2d ago
Why Is Plus Therapeutics Stock Gaining Friday?
Benzinga · 4d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 4d ago
Plus Therapeutics Appoints New Chief Development Officer
TipRanks · 6d ago
Plus Therapeutics appoints Eric Daniels as chief development officer
TipRanks · 6d ago
Plus Therapeutics names Eric Daniels chief development officer to advance clinical pipeline
Reuters · 6d ago
Press Release: Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline
Dow Jones · 6d ago
Plus Therapeutics Price Target Cut to $65.00/Share From $475.00 by Ascendiant Capital
Dow Jones · 6d ago
More
About PSTV
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. Combining image-guided local beta radiation and targeted drug delivery approaches, it is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). Its lead radiotherapeutic candidate, REYOBIQ (rhenium (186Re) obisbemeda), is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC) by direct localized delivery utilizing approved standard-of-care tissue access such as with convection-enhanced delivery (CED) and intraventricular brain (Ommaya reservoir) catheters. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers including primary and secondary liver cancers via intra-arterial injections.

Webull offers Plus Therapeutics Inc (USA) stock information, including NASDAQ: PSTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSTV stock methods without spending real money on the virtual paper trading platform.